|
Predictors of Physical health MSQoL-54 scales by IFN-β treatment (Multivariate hierarchical analysis) |
||||||||||||
| Energy |
Health perceptions |
Physical function |
Role limitation physical |
Bodily pain |
Social function |
|||||||
|
|
||||||||||||
| Effect |
β |
p |
β |
p |
β |
p |
β |
p |
β |
p |
β |
p |
| Intercept* |
45.11 |
<.0001 |
44.67 |
<.0001 |
69.40 |
<.0001 |
71.72 |
<.0001 |
74.23 |
<.0001 |
72.54 |
<.0001 |
| Age at inclusion |
-0.12 |
0.36 |
0.06 |
0.68 |
-0.4 |
0.01 |
-0.60 |
0.03 |
-0.36 |
0.04 |
0.06 |
0.66 |
| Gender (Male vs. Female) |
-0.51 |
0.84 |
2.00 |
0.52 |
1.07 |
0.75 |
-17.3 |
0.003 |
3.74 |
0.31 |
-0.32 |
0.90 |
| Disease duration |
-0.02 |
0.92 |
-0.36 |
0.08 |
0.10 |
0.64 |
0.19 |
0.60 |
-0.38 |
0.12 |
-0.30 |
0.10 |
| Disease course (SP vs. RR) |
9.54 |
0.03 |
7.35 |
0.16 |
-8.44 |
0.12 |
8.77 |
0.34 |
17.33 |
0.004 |
8.65 |
0.06 |
| Relapse rate 2-yrs before study entry |
0.37 |
0.90 |
-2.01 |
0.58 |
0.70 |
0.86 |
1.39 |
0.83 |
-0.20 |
0.96 |
3.76 |
0.24 |
| EDSS |
-2.33 |
0.06 |
-3.54 |
0.02 |
-8.44 |
<.0001 |
-4.69 |
0.09 |
-2.82 |
0.11 |
-2.65 |
0.05 |
| BDI |
-1.16 |
<.0001 |
-0.26 |
0.20 |
0.25 |
0.26 |
-0.92 |
0.01 |
0.22 |
0.36 |
-0.66 |
0.0004 |
| FSS |
-4.80 |
<.0001 |
-6.8 |
<.0001 |
-8.69 |
<.0001 |
-10.0 |
<.0001 |
-9.74 |
<.0001 |
-6.72 |
<.0001 |
| MMSE-c |
-0.19 |
0.71 |
-0.43 |
0.46 |
0.05 |
0.94 |
-1.90 |
0.10 |
0.02 |
0.98 |
-0.30 |
0.57 |
| IFN-β treatment (Yes vs No) |
1.43 |
0.65 |
3.56 |
0.32 |
1.20 |
0.77 |
5.03 |
0.50 |
4.54 |
0.32 |
0.23 |
0.94 |
| Relapse rate change after 2-yrs |
4.96 |
0.17 |
2.40 |
0.61 |
3.76 |
0.20 |
-2.71 |
0.69 |
2.96 |
0.54 |
6.77 |
0.08 |
| EDSS change after 2-yrs |
-0.11 |
0.95 |
-1.49 |
0.54 |
-4.54 |
0.003 |
0.59 |
0.86 |
0.70 |
0.77 |
-2.72 |
0.16 |
| BDI change after 2-yrs |
-0.67 |
0.0005 |
-0.48 |
0.05 |
-0.14 |
0.37 |
-1.59 |
<.0001 |
-0.82 |
0.002 |
-0.67 |
0.001 |
| FSS change after 2-yrs |
-5.20 |
<.0001 |
-4.89 |
0.001 |
-4.65 |
<.0001 |
-4.75 |
0.03 |
-5.98 |
0.0001 |
-4.39 |
0.0003 |
| MMSE-c change after 2-yrs |
-1.09 |
0.15 |
0.20 |
0.84 |
-0.10 |
0.87 |
-3.04 |
0.04 |
-0.64 |
0.53 |
0.18 |
0.81 |
| Time** |
8.67 |
0.004 |
3.36 |
0.37 |
-4.84 |
0.05 |
-1.00 |
0.86 |
-1.81 |
0.65 |
0.64 |
0.84 |
| Time × IFN-β treatment (Yes vs No) |
-0.76 |
0.86 |
-1.72 |
0.74 |
-6.15 |
0.07 |
-2.54 |
0.77 |
3.82 |
0.50 |
-1.73 |
0.69 |
|
*Intercept value represents the baseline mean score for reference group (Untreated) **Time value represents the mean score change for reference group (Untreated) after 2 years of follow-up | ||||||||||||
Simone et al. Health and Quality of Life Outcomes 2006 4:96 doi:10.1186/1477-7525-4-96 |
||||||||||||